Physician profile
Daniel Peter Fox
NPI 1295094548
$4,153.63
in general payments reported to CMS, 2019-2025
18 companies · $650 in 2025
The $650 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,015 · 2020: $136 · 2021: $402 · 2022: $770 · 2023: $536 · 2024: $645 · 2025: $650.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,831.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,830.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $615.37 | 2019-2022 | |
| Aerin Medical INC. | $599.94 | 2019-2024 | |
| Optinose US, INC. | $497.90 | 2021-2024 | |
| Inspire Medical Systems, INC. | $493.70 | 2022-2025 | Inspire |
| Medtronic, INC. | $346.16 | 2022-2025 | Propel |
| Intersect Ent, INC. | $286.19 | 2019-2021 | |
| Acclarent, INC | $225.48 | 2020-2023 | Relieva Spinplus, Trudi Nav Cable |
| Integra Lifesciences Corporation | $167.26 | 2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Neurent Medical Limited | $164.43 | 2025 | Neuromark Radiofrequency Console, Neuromark System |
| Hologic Sales and Service, LLC | $148.38 | 2024 | Coolseal Generator |
| Glaxosmithkline, LLC. | $125.00 | 2025 | Nucala |
| Genzyme Corporation | $121.50 | 2023 | |
| Alk-Abello, INC | $96.20 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $84.05 | 2019 | |
| Olympus America INC. | $82.68 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $56.17 | 2019-2021 | |
| Checkpoint Surgical, INC | $22.55 | 2019 | |
| Lilly USA, LLC | $20.67 | 2025 | Zepbound, Mounjaro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Fox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.